STRS Ohio’s Gyre Therapeutics GYRE Stock Holding History

STRS Ohio’s Portfolio GYRE Stock Details GYRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Hold	21,100	–	–	﹤0.01%	1619
2025 Q4	$149K	Hold	21,100	–	–	﹤0.01%	1664
2025 Q3	$157K	Buy	21,100 +7,800	+59%	+$59.2K	﹤0.01%	1657
2025 Q2	$97.8K	Buy	+13,300	New	+$116K	﹤0.01%	1872
2021 Q2	–	Sell	-893	Closed	-$33K	–	2314
2021 Q1	$33K	Buy	+893	New	+$40.8K	﹤0.01%	2076
2018 Q3	–	Sell	-467	Closed	-$37K	–	2138
2018 Q2	$40K	Buy	+467	New	+$81.9K	﹤0.01%	2011

Other funds holding GYRE

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

STRS Ohio's GYRE Position: Q1 2026 in Review

STRS Ohio held its Gyre Therapeutics (GYRE) position steady in Q1 2026 at 21,100 shares worth $147K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

STRS Ohio first reported a position in GYRE in Q2 2018 and has held it in 6 quarters since. The position peaked at $157K in Q3 2025. 56 funds tracked by Wall St. Rank hold GYRE as of Q1 2026.

STRS Ohio held 21,100 shares of Gyre Therapeutics worth $147K as of Q1 2026.
STRS Ohio left its Gyre Therapeutics share count unchanged in Q1 2026.
Gyre Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1619 holding.
STRS Ohio first reported a position in Gyre Therapeutics in Q2 2018 and has held it in 6 quarters since.
STRS Ohio's Gyre Therapeutics position peaked at $157K in Q3 2025.
56 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.